BTCA — Bactolac Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00Consumer DefensivesMid Cap
- $1.14bn
- $1.14bn
- $22.93m
Annual cashflow statement for Bactolac Pharmaceutical, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
C2001 September 30th | 2002 September 30th | R2003 September 30th | 2004 September 30th | 2005 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10KSB |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.981 | -2.16 | 1.94 | 4.24 | 1.88 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 2.64 | 1.59 | -0.951 | -0.238 | 0.004 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.683 | -1.64 | -0.541 | -0.891 | -0.223 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 3.18 | -1.46 | 0.668 | 2.1 | 2.92 |
| Capital Expenditures | -0.807 | -0.308 | -0.386 | -0.243 | -0.661 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.065 | 0.611 | 0.414 | 3.39 | -1.3 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.742 | 0.303 | 0.028 | 3.15 | -1.96 |
| Financing Cash Flow Items | 1.25 | 0 | -0.091 | -4.34 | -0.118 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2.35 | 1.17 | -0.371 | -4.51 | -2.07 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.085 | 0.011 | 0.326 | 0.743 | -1.11 |